The present study hypothesises that ACSL1 acetylation can be regulated by SIRT to enhance ACSL1 activity, to promote FAO, and ultimately affect NAFLD progression. The gene discussed is ACSL1; the disease is metabolic dysfunction-associated steatotic liver disease.